Showing 321 - 340 results of 872 for search '"preclinical"', query time: 0.05s Refine Results
  1. 321

    Glutamate Receptors in Neuroinflammatory Demyelinating Disease

    Published 2006-01-01
    “…The search for new MS treatments invariably employs EAE to determine drug activity and provide a rationale for exploring clinical efficacy. The preclinical development of compounds for MS has generally followed a conventional, immunotherapeutic route. …”
    Get full text
    Article
  2. 322

    New Antibody Conjugates in Cancer Therapy by Serengulam V. Govindan, David M. Goldenberg

    Published 2010-01-01
    “…The advantage of pretargeted RAIT over directly labeled MAbs is continuing to be validated in preclinical models of lymphoma and solid tumors. Importantly, the advantages of combining RAIT with radiation sensitizers, with immunotherapy, or a drug conjugate targeting a different antigen are being studied clinically and preclinically. …”
    Get full text
    Article
  3. 323

    Ubiquitination Enzymes in Cancer, Cancer Immune Evasion, and Potential Therapeutic Opportunities by Aiman B. Awan, Maryiam Jama Ali Osman, Omar M. Khan

    Published 2025-01-01
    “…We also discussed the recent update on small-molecule inhibitors and PROTACs and their progress in preclinical and clinical trials.…”
    Get full text
    Article
  4. 324

    Stem Cell Applications in Tendon Disorders: A Clinical Perspective by Mark Young

    Published 2012-01-01
    “…However, tendons usually heal with fibrosis and scar tissue, which has suboptimal tensile strength and is prone to reinjury, resulting in lifestyle changes with activity restriction. Preclinical studies show that cell therapies have the potential to regenerate rather than repair tendon tissue, a process termed tenogenesis. …”
    Get full text
    Article
  5. 325

    Stem Cell Tracking with Nanoparticles for Regenerative Medicine Purposes: An Overview by Lisa Accomasso, Clara Gallina, Valentina Turinetto, Claudia Giachino

    Published 2016-01-01
    “…Moreover, this review has summarized the advantages and applications of stem cell tracking with nanoparticles in experimental and preclinical studies and investigated present limitations for their employment in the clinical setting.…”
    Get full text
    Article
  6. 326

    CXC Chemokines in the Pathogenesis of Pulmonary Disease and Pharmacological Relevance by Kayode Komolafe, Maricica Pacurari

    Published 2022-01-01
    “…Furthermore, encouraging preclinical data has necessitated the progression of a few of these drugs into clinical trials in order to make the most effective use of interventions in the development of viable targeted therapeutics. …”
    Get full text
    Article
  7. 327

    Application of biomaterials in mesenchymal stem cell based endometrial reconstruction: current status and challenges by Ling He, Qianrong Li

    Published 2025-01-01
    “…This review discusses the use of various biomaterials in MSC-based therapies for endometrial reconstruction and summarizes evidence from preclinical and clinical studies, highlighting the efficacy and safety of these biomaterials. …”
    Get full text
    Article
  8. 328
  9. 329

    Potential roles for vitamin D in preventing and treating impulse control disorders, behavioral addictions, and substance use disorders: A scoping review by Laya Jalilian-Khave, Razi Kitaneh, Binah Baht Ysrayl, Anna Borelli, Melissa C. Funaro, Marc N. Potenza, Gustavo A. Angarita

    Published 2025-03-01
    “…This scoping review (OSF registered as 67yhb) examines preclinical and clinical studies exploring relationships between vitamin D in impulse control disorders, behavioral addictions, and substance use disorders. …”
    Get full text
    Article
  10. 330

    Perspectives for Clinical Translation of Adipose Stromal/Stem Cells by Mimmi Patrikoski, Bettina Mannerström, Susanna Miettinen

    Published 2019-01-01
    “…This review explores the different phases of in vitro and preclinical ASC characterisation and describes the development of appropriate potency assays. …”
    Get full text
    Article
  11. 331
  12. 332

    Anaplastic Thyroid Carcinoma: Current Treatments and Potential New Therapeutic Options with Emphasis on TfR1/CD71 by Rosalba Parenti, Lucia Salvatorelli, Gaetano Magro

    Published 2014-01-01
    “…This review briefly focuses on main molecular events that characterize ATC and provides an update about preclinical studies. In addition, the overexpression of transferrin receptor 1 (TfR1/CD71) by neoplastic cells of ATC is emphasized in that it could represent a potential therapeutic target. …”
    Get full text
    Article
  13. 333

    EVALUATION OF THE THERAPEUTIC EFFECTS OF SALVIA ROSMARINUS ESSENTIAL OIL ON NERVOUS SYSTEM DISORDERS by Malina Mihaela Visternicu, Viorica Rarinca, Vasile Burlui, Alin Ciobica

    Published 2025-02-01
    “…This review explores the therapeutic potential of rosemary in alleviating nervous system disorders such as Alzheimer's disease (AD), major depressive disorder (MDD), epilepsy, Parkinson's disease (PD), addiction, and attention-deficit hyperactivity disorder (ADHD). Preclinical and clinical research suggests that rosemary extracts, through their active compounds, may enhance cognitive function, protect neurons from oxidative stress, and modulate neurotransmitters involved in cognitive and emotional processes. …”
    Get full text
    Article
  14. 334

    Gelatin-based biomaterials as a delivery strategy for osteosarcoma treatment by Qifan Yang, Xingpeng Chen, Jing Liu, Yeteng He

    Published 2025-01-01
    “…At present, gelatin-based hydrogels, gelatin scaffolds, and gelatin-based nanoparticles have been reported in preclinical studies. In this article, we introduce the application of gelatin-based biomaterials in the treatment of osteosarcoma, and summarize and look forward to them.…”
    Get full text
    Article
  15. 335

    Information and communication technologies' knowledge and use by Health Technology teachers by Rafaela Nayibe Curi Mendoza

    Published 2023-07-01
    “…The studied population was the Department of Health Technology's professors of the Victoria de Girón  Basic and Preclinical Sciences Institute  in 2021. Summary measures were used for the variables according to their nature.…”
    Get full text
    Article
  16. 336

    Intratumor heterogeneity in KRAS signaling shapes treatment resistance by Oleksi Petrenko, Varvara Kirillov, Stephen D'Amico, Nancy C. Reich

    Published 2025-02-01
    “…Combination immunotherapy leads to durable tumor regression in preclinical models.…”
    Get full text
    Article
  17. 337

    EGFR Amplification and Glioblastoma Stem-Like Cells by Katrin Liffers, Katrin Lamszus, Alexander Schulte

    Published 2015-01-01
    “…GS-cells with retained EGFR amplification could overcome the limitations of current in vitro model systems and contribute significantly to preclinical research on EGFR-targeted therapy. This review recapitulates recent methodological approaches to expand stem-like cells from GBM with different EGFR status in order to maintain EGFR-dependent intratumoral heterogeneity in vitro. …”
    Get full text
    Article
  18. 338

    New Immunotherapeutic Approaches for Glioblastoma by Gustavo Ignacio Vázquez Cervantes, Dinora F. González Esquivel, Saúl Gómez-Manzo, Benjamín Pineda, Verónica Pérez de la Cruz

    Published 2021-01-01
    “…In this review, we summarize and discuss promising immunotherapies for GBM currently under preclinical investigation as well as in clinical trials.…”
    Get full text
    Article
  19. 339

    New Therapeutic Approaches for the Treatment of Rheumatoid Arthritis may Rise from the Cholinergic Anti-Inflammatory Pathway and Antinociceptive Pathway by Xiao Hua Pan, Jianxin Zhang, Xiaowei Yu, Ling Qin, Ligeng Kang, Peng Zhang

    Published 2010-01-01
    “…Therefore, new therapeutic approaches may rise from these two newly discovered pathways. More preclinical experiments and clinical trials are required to confirm our viewpoint.…”
    Get full text
    Article
  20. 340

    Reenvisioning Traditional to Regenerative Therapeutic Advances in Managing Nonalcoholic Fatty Liver Disease in Diabetes Mellitus by Lung-Wen Tsai, Yi-Hsiang Lu, Rajni Dubey, Jeng-Fong Chiou

    Published 2021-01-01
    “…Based on these abovementioned approaches, we aimed to comprehensively analyze various preclinical and clinical studies from traditional to regenerative therapeutic approaches in managing concomitant NAFLD and T2DM.…”
    Get full text
    Article